The remarkable story of a wonder drug, which now comes to an end in the primary prevention setting: say bye-bye to aspirin!
- PMID: 30590516
- DOI: 10.1093/eurheartj/ehy872
The remarkable story of a wonder drug, which now comes to an end in the primary prevention setting: say bye-bye to aspirin!
Comment on
-
Efficacy and safety of aspirin for primary prevention of cardiovascular events: a meta-analysis and trial sequential analysis of randomized controlled trials.Eur Heart J. 2019 Feb 14;40(7):607-617. doi: 10.1093/eurheartj/ehy813. Eur Heart J. 2019. PMID: 30561620
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources

